Send me a link:

*Text messaging rates may apply.

 Dow Down0.21% Nasdaq Down0.08%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.24 Down 0.02(1.67%) 9:32AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 15,289   323   323   324  
Cost of Revenue -   -   -   -  
Gross Profit 15,289   323   323   324  
Operating Expenses
Research Development11,767  11,889  19,414  16,203  
Selling General and Administrative5,555  4,499  4,440  7,324  
Non Recurring3,859  4  77  7,869  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,892) (16,069) (23,608) (31,072)
Income from Continuing Operations
Total Other Income/Expenses Net23  20  58  (16)
Earnings Before Interest And Taxes(5,869)(16,049)(23,550)(31,088)
Interest Expense581  676  756  825  
Income Before Tax(6,450)(16,725)(24,306)(31,913)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(6,450)(16,725)(24,306)(31,913)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (6,450) (16,725) (24,306) (31,913)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (6,450) (16,725) (24,306) (31,913)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.